Showing results (11-20 of 406) with videos related to
Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitorsEmiliano Calvo, José BaselgaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
The epidermal growth factor receptor pathway: a model for targeted therapyMaurizio Scaltriti, José BaselgaNature Clinical Practice. Oncology|July 9, 2008
The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2Aleix Prat, José BaselgaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Pharmacology in the Era of Targeted Therapies: The Case of PI3K InhibitorsEneda Toska, José BaselgaCurrent Oncology Reports|June 5, 2002
Targeting epidermal growth factor receptor in lung cancerJosé Baselga, Joan AlbanellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
Neoadjuvant therapy as a platform for drug development and approval in breast cancerAditya Bardia, José BaselgaNPJ Breast Cancer|May 21, 2021
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is nowIlana Schlam, Sandra M SwainExpert Opinion on Drug Safety|March 17, 2016
Pertuzumab for the treatment of breast cancer: a safety reviewJennifer Gao, Sandra M SwainCancer|May 27, 2010
Primary systemic chemotherapy for inflammatory breast cancerSarah Sinclair, Sandra M SwainExpert Opinion on Investigational Drugs|March 7, 2008
Ixabepilone for the treatment of solid tumors: a review of clinical dataNeelima Denduluri, Sandra M SwainPageof 41